Navigation Links
New Data From REALISTIC Study Showed Cimzia® (certolizumab pegol) Provided Rapid and Sustained Efficacy, Over 28 Weeks, in a Broad Population of Patients With Moderate to Severe Rheumatoid Arthritis (RA) Including Those Who Discontinued Prior Anti-T
Date:11/7/2011

itor use, concomitant use of methotrexate (MTX), and disease duration (<2 y vs greater than or equal to 2 y). Treatment effect differences between subgroups were assessed by interactions (treatment by covariate) at 10% significance level.

Active RA patients with inadequate response to greater than or equal to 1 DMARD were randomized 4:1 to CZP 400mg (n=851) at Weeks 0, 2 and 4 followed by 200mg every 2 weeks or placebo injection (control, n=212) every 2 weeks added to current therapy. PROs included fatigue (Fatigue Assessment Scale [FAS; 0–10 numeric rating scale]), pain (0–100mm visual analogue scale [VAS]), and patient's global assessment of disease activity (PtGA, 0–100mm VAS). The minimal clinically important difference (MCID) is a clinically relevant change in a patient's status. The percentage of patients reporting MCIDs was determined: greater than or equal to 1 for FAS, greater than or equal to 6 for MOS-SPI, and greater than or equal to 10mm for pain-VAS and PtGA. Correlations between PROs and DAS28 were also assessed (Pearson correlations [rho], CZP group only).

About CIMZIA®

Cimzia® is the only PEGylated anti-TNF (Tumor Necrosis Factor). Cimzia® has a high affinity for human TNF-alpha, selectively neutralizing the pathophysiological effects of TNF-alpha. Over the past decade, TNF-alpha has emerged as a major target of basic research and clinical investigation. This cytokine plays a key role in mediating pathological inflammation, and excess TNF-alpha production has been directly implicated in a wide variety of diseases. The U.S. Food and Drug Administration (FDA) has approved Cimzia® for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy and for the treatment of adults with moderat
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... VICTORIA, Texas , March 27, 2015  Victoria Vein ... removal services with the Astanza Duality laser in ... of vein disease as well as advanced laser treatments for ... are entering the tattoo industry to provide more services for ... Surgery has helped many Victoria residents ...
(Date:3/27/2015)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is celebrating a key ... Complete Knee System. , ... Zimmer first introduced the NexGen knee system, with its innovative ... million implantations of the NexGen knee have taken place worldwide. ... knee demonstrates the importance of design innovation and component quality for surgeons ...
(Date:3/27/2015)... , March 27, 2015 ... prospects for leading ophthalmic drug companies  What ... pharma ophthalmic industry ? Visiongain,s brand new report ... opportunities and prospects there. Our 242-page report ... lucrative areas in the industry and the future market ...
Breaking Medicine Technology:Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7
... 7, 2012  BioSpecifics Technologies Corp. (NASDAQ: BSTC ), ... as XIAFLEX ® in the U.S. and XIAPEX ® ... and time for its conference call and live audio webcast ... a corporate update. The conference call is now scheduled for ...
... 2012 A new analysis concludes that rituximab, a drug ... lasting at least five years in approximately one quarter of ... due to chronic immune thrombocytopenic purpura (ITP). In study ... , the Journal of the American Society of Hematology ...
Cached Medicine Technology:BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012 2Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets 2Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets 3
(Date:3/30/2015)... 30, 2015 South Coast Surety is pleased ... Bond Representative. Richard has been known to the management of ... Richard attended the University of Georgia, majoring in Banking and ... the sales and sales management of business equipment for a ... Most recently, Richard was a senior officer with a National ...
(Date:3/30/2015)... CA (PRWEB) March 30, 2015 Corra Group ... to accommodate the needs of every industry that requires this ... face compliance mandates or seek new ways to increase productivity ... new drug panels that will help detect substance abuse with ... have mandated drug tests,” said Corra Group Co-Founder, Gordon Basichis. ...
(Date:3/30/2015)... City, Mo. (PRWEB) March 30, 2015 ... App, a mobile library of medications used in ... free for iPhone, iPad and Android—is a convenient, ... published annually since 1999. The useful resource provides ... including purpose, dosage and frequency, side effects, emergency ...
(Date:3/30/2015)... TherapySites, the leading ... professionals, announced today its affiliation with BehaveNet. ... their online marketing solutions to BehaveNet members, adding ... continue to see advancements in technology, it is ... in order to succeed,” said Denise Marshall, Business ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 National Nutrition ... stock of their eating habits and commit to nutritious decisions ... the future. According to a recent study from the U.S. ... comes from snack food. Making healthy snack choices needs to ... a busy society constantly on the go. , Each day, ...
Breaking Medicine News(10 mins):Health News:Richard Ford Joins South Coast Surety Contract Surety Team 2Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 2Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 3Health News:Popular Publication on Behavioral Health Medications Now An App 2Health News:TherapySites (Websites for Therapists) Partners with BehaveNet 2Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 2Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 3
... ... Within Seconds, WESTCHESTER, Ill., ... medical treatments, has,received 510(k) clearance from the U.S. Food and Drug ... being used,at several clinical cooperation sites worldwide., In the past, ...
... and Charitable Care and Coverage, OAKLAND, Calif., ... has approved more than 415 community benefit grants ... quarter of 2008.,The quarter,s contributions continue to support ... measurable impact on the health of,its communities., ...
... LOUIS, July 29 KV Pharmaceutical Company,(NYSE: KVa/KVb), ... of its inventory,of certain drug products -- principally ... inventory disposal will signal the,conclusion of previously disclosed ... products containing guaifenesin that were marketed by,ETHEX as ...
... eight,Bay Area nursing homes held simultaneous demonstrations Tuesday ... make much,needed improvements in resident care and patient ... came together to fight for our,residents, right to ... a,Certified Nursing Assistant at The Ridge Care & ...
... of underlying risk for dementia, study suggests , , TUESDAY, July ... Alzheimer,s disease doesn,t provide a complete picture of overall risk, ... , Previous research has shown that people with the E4 ... developing Alzheimer,s, but this new Duke University Medical Center-led study ...
... FGXI ), a leading designer and marketer of ... results,for its second quarter and six months ended June ... ), Highlights for the quarter include: ... the current quarter from,$62.6 million in the second quarter ...
Cached Medicine News:Health News:BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy 2Health News:BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy 3Health News:BrainLAB Announces 510(k) FDA Clearance of Monte Carlo Dose Engine for Stereotactic Radiosurgery and Radiation Therapy 4Health News:Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008 2Health News:Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008 3Health News:KV Set to Dispose of Previously Written Off Guaifenesin Inventory 2Health News:KV Set to Dispose of Previously Written Off Guaifenesin Inventory 3Health News:Caregivers Demand Better Patient Care at Eight Bay Area Nursing Homes 2Health News:Family History May Add to Alzheimer's Puzzle 2Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 2Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 3Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 4Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 5Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 6Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 7Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 8Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 9Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 10Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 11Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 12Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 13Health News:FGX International Reports Strong Sales and Earnings Growth for the Second Quarter and First Six Months of 2008 14
... When someone suffers an episode of ... right away. The QuikDraw PRO quickly restores ... immediate pain relief.,With just a few sizes ... clothing sizes, the QuikDraw PRO will reduce ...
Shoulder Immobilizer with Body Strap Navy blue cotton. Thumb look helps keep hand in neutral position. Padded, 2" blue pile material laminated to foam shoulder and body strap. Fits left or right. 5/p...
... Shoulder Immobilizer with Contoured ... Navy cotton sling with foam-padded ... body straps. Quick-release closure buckles. ... 35 covered abduction wedge to ...
... Combining the therapeutic benefits of controlled ... hemarthrosis, swelling, and pain. The anatomically designed ... treatment.,The Shoulder Cryo/Cuff can be ordered with ... to larger chest circumferences.,All Cryo/Cuffs can be ...
Medicine Products: